{"schema_version":"1","generated_at":"2026-10-29T11:30:13.433Z","data_as_of":null,"url":"https://www.findmykol.com/kol/hyo-han","json_url":"https://www.findmykol.com/kol/hyo-han/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"hyo-han","name":"Hyo Han","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Moffitt Cancer Center","institution_url":"https://www.findmykol.com/institution/moffitt-cancer-center","city":"Tampa","state":"FL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"npi":"1306055348","orcid":"0000-0002-0072-0257","openalex":"A5059240684"},"summary":"Hyo Han is an Oncology physician affiliated with Moffitt Cancer Center. OpenAlex indexes 274 publications with 4,957 citations (h-index 36); ClinicalTrials.gov lists 4 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":274,"cited_by_count":4957,"h_index":36,"latest_activity_year":2025,"source":"works"},"trials":{"count":4,"shown":3,"withheld":1,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT05325632","title":"Study of HER2 Directed Dendritic Cell (DC1) Vaccine + Weekly Paclitaxel, Trastuzumab & Pertuzumab","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","source_url":"https://clinicaltrials.gov/study/NCT05325632","trial_url":"https://www.findmykol.com/trial/NCT05325632"},{"nct":"NCT03384914","title":"Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer","phase":"PHASE2","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","source_url":"https://clinicaltrials.gov/study/NCT03384914","trial_url":"https://www.findmykol.com/trial/NCT03384914"},{"nct":"NCT03112590","title":"Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer","phase":"PHASE1/PHASE2","status":"COMPLETED","role":"Overall official","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","source_url":"https://clinicaltrials.gov/study/NCT03112590","trial_url":"https://www.findmykol.com/trial/NCT03112590"}],"source":"trials"},"payments":{"company_count":8,"program_years":{"first":2021,"last":null},"rows_total":16,"shown":3,"withheld":13,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":2347.02,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306055348"},{"payer":"PFIZER INC.","program_year":2025,"amount_usd":2268.49,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306055348"},{"payer":"Lilly USA, LLC","program_year":2025,"amount_usd":228.85,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1306055348"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1306055348","source":"payments"},"publications":{"total":49,"shown":5,"withheld":44,"matched_by":"OpenAlex author record","recent":[{"title":"Gedatolisib in combination with palbociclib and endocrine therapy in women with hormone receptor-positive, HER2-negative advanced breast cancer: results from the dose expansion groups of an open-label, phase 1b study","year":2024,"journal":"The Lancet Oncology","source_url":"https://doi.org/10.1016/s1470-2045(24)00034-2","status":"verified"},{"title":"Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial","year":2023,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-023-02210-0","status":"verified"},{"title":"Early-Stage Triple-Negative Breast Cancer Journey: Beginning, End, and Everything in Between","year":2023,"journal":"American Society of Clinical Oncology Educational Book","source_url":"https://doi.org/10.1200/edbk_390464","status":"verified"},{"title":"Author Correction: Oncolytic T-VEC virotherapy plus neoadjuvant chemotherapy in nonmetastatic triple-negative breast cancer: a phase 2 trial","year":2023,"journal":"Nature Medicine","source_url":"https://doi.org/10.1038/s41591-023-02309-4","status":"verified"},{"title":"Abstract GS3-03: GS3-03 ARV-471, a PROTAC® estrogen receptor (ER) degrader in advanced ER-positive/human epidermal growth factor receptor 2 (HER2)-negative breast cancer: phase 2 expansion (VERITAC) of a phase 1/2 study","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/1538-7445.sabcs22-gs3-03","status":"verified"}],"source":"works"},"contact":{"address_1":"12902 USF MAGNOLIA DR","city":"Tampa","state":"FL","zip":"336129416","phone":"813-745-4933","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1306055348","source":"identity"},"similar":[{"name":"Ignacio Wistuba","slug":"ignacio-wistuba","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/ignacio-wistuba","json_url":"https://www.findmykol.com/kol/ignacio-wistuba/profile.json"},{"name":"Christine Chung","slug":"christine-chung","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/christine-chung","json_url":"https://www.findmykol.com/kol/christine-chung/profile.json"},{"name":"Jonathan Strosberg","slug":"jonathan-strosberg","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/jonathan-strosberg","json_url":"https://www.findmykol.com/kol/jonathan-strosberg/profile.json"},{"name":"Nikhil Khushalani","slug":"nikhil-khushalani","institution":"Moffitt Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/nikhil-khushalani","json_url":"https://www.findmykol.com/kol/nikhil-khushalani/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":1,"payments":13,"publications":44}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-07-22","provider_certified":"2022-07-22","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}